InvestorsHub Logo
Followers 2
Posts 44
Boards Moderated 0
Alias Born 08/17/2020

Re: None

Thursday, 10/14/2021 7:25:18 AM

Thursday, October 14, 2021 7:25:18 AM

Post# of 200269
c&en Discovery Report featuring Dr. Gaurav Chandra …

Perhaps this already made the rounds here, but I’ve been unable to find traction in discussing this elsewhere.

Has anyone seen the recent Discovery Report magazine issue “Antivirals for The Future”, published by c&en in Q3 2021? The magazine features an article titled “8 experts weigh in on the future of antivirals.” The first expert featured is Dr. Chandra and includes this excerpt from the author:

Enzolytics had previously found one of the HIV sites and developed an antibody to target it; that antibody is now in clinical trials.



This is in reference to an antibody targeting HIV discovered as a result of AI. While Chandra is quoted several times in the article, this except is not a direct quote — however, it is presumably a statement made by Chandra (and likely approved by him before publication). The author goes on to distinguish this HIV antibody from ENZC’s antibody which targets covid, saying the company has plans to start clinical trials on the most promising covid mAb candidates early next year.

Given what we know, I find this to be a peculiar statement at odds with what we’ve been told. I’m curious to hear anyone’s thoughts.

(FWIW, I emailed the publication asking for clarification.)